BridgeMD
New treatment option for Stillbirth
Official title Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach
ClinicalTrials.gov ID: NCT06273007
What this study is testing
- What it's testing
- Overall Objective To introduce PartoMa approach (locally agreed and achievable intrapartum guidelines and a continual in-house training program) to Ethiopian context through continuous fetal heart rate (FHR) monitoring using MOYO device and co-creation of context specific intrapartum care guideline for improving decision making in intrapartum care in Eastern Ethiopia. Interventions 1.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- All women in labour delivering at the study site and their outcome, July - September 2023 and July -September 2025
- All birth attendant at the study site in obstetrics and gynecology departments during the baseline and intervention period, July - September 2023 and...
The study team makes the final eligibility decision.
Where it's taking place
- Harar, Oromiya, Ethiopia
- Harar, Ethiopia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Harar, Oromiya, Ethiopia; Harar, Ethiopia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.